Healthcare decision-making applications using multicriteria decision analysis: A scoping review

被引:48
作者
Glaize, Annabelle [1 ]
Duenas, Alejandra [2 ]
Di Martinelly, Christine [1 ]
Fagnot, Isabelle [3 ]
机构
[1] IESEG Sch Management, LEM CNRS UMR 9221, Management Dept, Lille, France
[2] CERFIGE, ICN Business Sch, Business Environm, Nancy, France
[3] Audencia Business Sch, Management Dept, Nantes, France
关键词
applications; healthcare areas; MCDA; methods; multicriteria decision analysis; scoping review; ANALYTIC HIERARCHY PROCESS; BENEFIT-RISK-ASSESSMENT; DISCRETE-CHOICE EXPERIMENT; MULTIPLE CRITERIA; ANALYSIS MCDA; TECHNOLOGY-ASSESSMENT; EVIDEM FRAMEWORK; CANCER-TREATMENT; RARE DISEASES; SELECTION;
D O I
10.1002/mcda.1659
中图分类号
C93 [管理学];
学科分类号
12 ; 1201 ; 1202 ; 120202 ;
摘要
The objective of this study is to review applications of multicriteria decision analysis (MCDA) methods to provide structure for and practical insights on how MCDA methods are applied in different healthcare areas. Four databases (Embase, Medline, Web of Science, and PubMed) were searched from 1980 to February 7, 2018. A scoping review was performed to outline the most frequently applied MCDA methods, in which only case studies were considered, as the objective was to assess the applications of MCDA methods. Seventy case studies were selected. The review showed that the first real-life application was published in 1990. With regard to areas of application, three aspects were analysed: type of health services (public or private), type of intervention (preventive, diagnostic, or treatment), and healthcare area (policymaking; resource allocation; health technology assessment; pharmaceutics; and hospital, clinical, or patient level). Data revealed that MCDA was principally used in public health services (n = 59). Three types of interventions were identified: prevention (n = 36), diagnosis (n = 32), and treatment (n = 2). An MCDA process of application was then followed to provide practical insights. During the problem-structuring phase, results showed that processes for selecting stakeholders and criteria differed among healthcare areas. For model building, authors preferred value measurement methods and especially the analytical hierarchy process. Authors of the 70 case studies included and confirmed the usefulness of MCDA in different healthcare contexts. The stakeholders, criteria, and MCDA methods chosen differ from one study to another, answering different research objectives in different healthcare areas. This scoping review highlights the importance of each MCDA step (using Belton and Stewart's framework), from problem structuring (including the selection of stakeholders) to the model building phase (encompassing the selection of the appropriate MCDA method). We recommend structured and justified analysis so that decision makers and stakeholders can feel confident during the application process in order to make final decisions more meaningful. Further work is needed to help researchers and decision makers when choosing a suitable MCDA method.
引用
收藏
页码:62 / 83
页数:22
相关论文
共 94 条
[81]   Hospital site selection using fuzzy AHP and its derivatives [J].
Vahidnia, Mohammad H. ;
Alesheikh, Ali A. ;
Alimohammadi, Abbas .
JOURNAL OF ENVIRONMENTAL MANAGEMENT, 2009, 90 (10) :3048-3056
[82]   Path analysis and multi-criteria decision making: An approach for multivariate model selection and analysis in health [J].
Vasconcelos, AGG ;
Almeida, RMVR ;
Nobre, FF .
ANNALS OF EPIDEMIOLOGY, 2001, 11 (06) :377-384
[83]   Multi criteria decision making to select the suitable method for the preparation of nanoparticles using an analytical hierarchy process [J].
Velmurugan, R. ;
Selvamuthukumar, S. ;
Manavalan, R. .
PHARMAZIE, 2011, 66 (11) :836-842
[84]   ASSESSING THE VALUE OF TREATMENTS FOR RARE DISEASES USING AN MCDA-BASED APPROACH: METHODOLOGICAL AND ETHICAL FOUNDATIONS OF CRITERIA SELECTION AND FRAMEWORK DEVELOPMENT [J].
Wagner, M. ;
Khoury, H. ;
Willet, J. ;
Rindress, D. ;
Goetghebeur, M. .
VALUE IN HEALTH, 2014, 17 (03) :A7-A7
[85]   Exploring the perspectives and preferences for HTA across German healthcare stakeholders using a multi-criteria assessment of a pulmonary heart sensor as a case study [J].
Wahlster, Philip ;
Goetghebeur, Mireille ;
Schaller, Sandra ;
Kriza, Christine ;
Kolominsky-Rabas, Peter .
HEALTH RESEARCH POLICY AND SYSTEMS, 2015, 13
[86]  
Wang Wen-Liang, 2007, J Nurs Res, V15, P255
[87]   Benefit-Risk Assessment of Statins (Lipid Lowering Agents): A Multi-Criteria Decision Analysis [J].
Wanishayakorn, Tanatape ;
Ngorsuraches, Surachat .
JOURNAL OF MULTI-CRITERIA DECISION ANALYSIS, 2016, 23 (1-2) :28-39
[88]   Two Approaches to Incorporate Clinical Data Uncertainty into Multiple Criteria Decision Analysis for Benefit-Risk Assessment of Medicinal Products [J].
Wen, Shihua ;
Zhang, Lanju ;
Yang, Bo .
VALUE IN HEALTH, 2014, 17 (05) :619-628
[89]   ESTIMATING THE PROBABILITY OF A RECOMMENDATION FOR REIMBURSEMENT FOR A NEW DRUG IN THE UK USING AN MCDA APPROACH [J].
Williams, P. ;
Mauskopf, J. A. ;
Kilburg, A. ;
Lebiecki, J. .
VALUE IN HEALTH, 2012, 15 (07) :A309-A310
[90]  
Wilson Edward, 2007, J Health Serv Res Policy, V12, P80, DOI 10.1258/135581907780279495